Evidence map›Paper›PMID 40661937›Full record

ArticleFrontiers in immunology2025

An assembled molecular signaling map of interleukin-24: a resource to decipher its multifunctional immunoregulatory role in pathophysiological conditions.

Anjana Aravind, Vineetha Shaji, Mukhtar Ahmed, Shobha Dagamajalu, Manavalan Vijayakumar, Thottethodi Subrahmanya Keshava Prasad, Rajesh Raju

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anjana AravindCenter for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
Vineetha ShajiCenter for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
Mukhtar AhmedDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Shobha DagamajaluCenter for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
Manavalan VijayakumarDepartment of Surgical Oncology, Yenepoya Medical College, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
Thottethodi Subrahmanya Keshava PrasadCenter for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
Rajesh RajuCenter for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Interleukin-24 (IL-24) is a cytokine belonging to the IL-10 family with immunoregulatory properties. It is known to induce cellular responses in various disease conditions, including inflammatory, infectious diseases, and cancer, in a receptor-dependent and independent manner. IL-24 is induced by both immune and non-immune cells and acts on a vast array of target cells to regulate various biological processes. The antitumor and immunoregulatory properties of IL-24 support its application as a therapeutic agent in a vast array of pathological conditions. Characterizing the molecular events associated with its immunomodulatory properties is essential for evaluating its utility in cancer immunotherapy. Methods: The data related to signaling events induced by IL-24 were then manually annotated and cataloged from the literature pertaining to IL-24 signaling. The cataloged molecular events were then manually drawn based on the topology as a signaling pathway map of IL-24. Results: Based on the data mined from published literature, we assembled IL-24-regulated signaling events linked to its immunoregulatory and anti-tumor activities. The receptor-ligand interaction of IL-24 regulates multiple downstream signaling cascades, leading to antitumor activities alongside inducing inflammatory reactions and anti-infectious processes. We provide a signaling pathway map of IL-24 consisting of 433 mRNAs/proteins and their 613 signaling events. Discussion: We believe this map would serve as a knowledge base for reference and one-go visualization of the signaling events identified to be induced by IL-24. Moreover, this map is made available (https://ciods.in/il24/) for the researchers to explore the role of IL-24 in various pathophysiological conditions through the gene set enrichment of transcriptomics or proteomics datasets from various disease conditions.

Indexed as

InterleukinsSignal TransductionAnimalsHumansImmunomodulationInterleukin-24NeoplasmsInterleukin-24Interleukinsimmune cellsimmuno-stimulationsignaling pathwaytherapeutic agenttumor suppressor cytokine

Identifiers

PMID40661937
PMCPMC12257977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.